Fieldview Capital Management’s Abbott ABT Stock Holding History

Fieldview Capital Management’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,183	Closed	-$1.63M	–	473
2025 Q3	$1.63M	Buy	+12,183	New	+$1.6M	0.27%	132
2025 Q2	–	Sell	-2,472	Closed	-$328K	–	329
2025 Q1	$328K	Buy	+2,472	New	+$315K	0.05%	326

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fieldview Capital Management's ABT Position: Q4 2025 in Review

Fieldview Capital Management sold out of Abbott (ABT) in Q4 2025, closing a stake of 12,183 shares — an estimated $1.63M sold.

Fieldview Capital Management first reported a position in ABT in Q1 2025 and held it in 2 quarters. The position peaked at $1.63M in Q3 2025. 3,284 funds tracked by Wall St. Rank hold ABT as of Q4 2025.

Fieldview Capital Management reported no remaining Abbott position as of Q4 2025 after selling out during the quarter.
Fieldview Capital Management sold 12,183 Abbott shares in Q4 2025, an estimated $1.63M.
Fieldview Capital Management first reported a position in Abbott in Q1 2025 and held it in 2 quarters.
Fieldview Capital Management's Abbott position peaked at $1.63M in Q3 2025.
3,284 funds tracked by Wall St. Rank held Abbott as of Q4 2025.

Based on Fieldview Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.